TotalMarketCap

Bicycle Therapeutics

BCYCNasdaq United KingdomHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$243.884 M

$3.48 -6.47%

Close of 6 Nov 2026

As of 6 Nov 2026, Bicycle Therapeutics (BCYC) has a market capitalization of $243.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$72.6M

#2590 by revenue

Earnings

-$219.0M

Loss-making

Shares outstanding

69,993,013

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #231BioAge LabsBIOA$254.3M
  2. #232Larimar TherapeuticsLRMR$244.6M
  3. #233Bicycle TherapeuticsBCYC$243.9M
  4. #234Lifecore Biomedical, Inc. DeLFCR$242.4M
  5. #235Amarin Corp PlcukAMRN$238.3M

What if Bicycle Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$402,844.32

Per share 115,780× higher

Bitcoin $1.53T

$21,797.20

Per share 6,265× higher

Apple $5.02T

$71,558.19

Per share 20,566× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Bicycle Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.